Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516458 · ClinicalTrials.gov registry record

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

A clinical trial of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06516458: Recruiting study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Shirley Ryan AbilityLab.

NCT06516458 is a study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 40 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516458, a study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Interventions

  • DIAGNOSTIC_TEST Camera Based Kinematic Analysis

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07
Est. Completion 2026-07
Shirley Ryan AbilityLab

138 total trials

What NCT06516458 shows while recruiting

NCT06516458 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Camera Based Kinematic Analysis is the first listed.

NCT06516458 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06516458 about?

NCT06516458 is a clinical study titled "Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis". The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

What is the current status of trial NCT06516458?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-07. Estimated completion is 2026-07.

What conditions does trial NCT06516458 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (Relapsing Remitting), Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Relapse.

What interventions are being tested in trial NCT06516458?

The interventions under investigation include: Camera Based Kinematic Analysis (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06516458?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06516458 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06516458's enrollment target sits among peer trials

40 197th of 315 higher than 108 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06516458, the US trial registry maintained by the National Library of Medicine. NCT06516458 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.